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SUMMARY 27 
The E. coli O157:H7 FepE protein regulates lipopolysaccharide (LPS) O-antigen (Oag) chain 28 
length to confer a very long (VL) modal chain length of >80 Oag repeat units (RUs). The 29 
mechanism by which FepE regulates Oag modal chain length and the regions within it that are 30 
important for its function remain unclear. Studies on the structure of FepE show that the protein 31 
oligomerises. However the exact size of the oligomer is in dispute, leading to a further unclear view 32 
of its mechanism. Guided by information previously obtained for regions known to be important for 33 
Oag modal chain length determination in the homologous Shigella flexneri WzzBSF protein, a set of 34 
FepE mutant constructs with single amino acid substitutions was created. Analysis of the resulting 35 
LPS conferred by these mutant His6-FepE proteins showed that amino acid substitutions of leucine 36 
168 (L168) and aspartic acid 268 (D268) resulted in LPS with consistently shortened Oag chain 37 
lengths of <80 Oag RUs. Substitution of FepE’s transmembrane (TM) cysteine residues did not 38 
affect function. Chemical cross-linking experiments on mutant FepE proteins showed no consistent 39 
correlation between oligomer size and functional activity, and mass spectrometry analysis of FepE 40 
oligomers indicated that the in vivo size of FepE is consistent with a maximum size of a hexamer. 41 
Our findings suggest that different FepE residues, mainly located within the internal cavity of the 42 
oligomer, contribute to Oag modal chain length determination but not the oligomeric state of the 43 
protein. 44 
45 
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INTRODUCTION 46 
Lipopolysaccharide (LPS) is an important virulence factor of many Gram negative bacteria and 47 
generally consists of 3 distinct regions: the membrane anchored lipid A domain, the core sugar 48 
region and the O-antigen (Oag) polysaccharide chains (Raetz & Whitfield, 2002). As with other 49 
members of the family Enterobacteriaceae, the genes encoding enzymes for Oag biosynthesis and 50 
polymerization are mainly found in the bacterial chromosome, but can also be plasmid-encoded 51 
(Raetz & Whitfield, 2002). Oag is a polymer of sugar repeat units (RUs) which define the Oag 52 
serotype specificity. The basic Oag RU of Shigella flexneri is a tetrasaccharide made up of three 53 
rhamnose sugars and one N-acetylglucosamine sugar. The following describes the Oag synthesis 54 
strategy in S. flexneri and E. coli K-12 known as the Wzy-dependant polymerisation pathway 55 
(Morona et al., 2009; Raetz & Whitfield, 2002; Samuel & Reeves, 2003; Tocilj et al., 2008). 56 
Biosynthesis of the Oag is initiated on the cytoplasmic side of the inner membrane. After a series of 57 
successive glycoyl transferase reactions, a RU is assembled on the membrane-bound carrier 58 
undecaprenyl pyrophosphate (Und-PP) and is then transferred across to the periplasmic side of the 59 
membrane by the Wzx flippase. Oag RUs then undergo polymerisation by the Wzy polymerase and 60 
are attached onto the lipid A-core molecule by the WaaL ligase to form a chain of Oag RUs on a 61 
complete LPS molecule. The number of Oag RUs can vary considerably from 0 to >100, are non-62 
randomly distributed into distinct modal lengths, and are controlled by Oag chain length regulators 63 
belonging to the polysaccharide co-polymerase class 1a (PCP1a) protein family (Morona et al., 64 
2000). PCP1a proteins have N-terminal and C-terminal transmembrane helices (TM1 and TM2) 65 
which flank a periplasmic polypeptide segment that contains predicted coiled-coil regions. LPS Oag 66 
modal chain length regulation has an important role in the pathogenesis of different bacteria (al-67 
Hendy et al., 1992; Crawford et al., 2012; Hong & Payne, 1997; Kintz et al., 2008; Murray et al., 68 
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2003; Murray et al., 2005; Najdenski et al., 2003; Van Den Bosch et al., 1997; Van Den Bosch & 69 
Morona, 2003; Zhang et al., 1997). 70 
  71 
The E. coli O157:H7 PCP1a protein FepE regulates LPS Oag chain length to confer very long (VL) 72 
modal chain lengths of >80 Oag RUs (Tocilj et al., 2008). The mechanism by which FepE regulates 73 
LPS Oag modal chain length and the regions within it that are important for its function remains 74 
unclear. Studies on the structure of FepE show that the protein oligomerises, but the size of this 75 
oligomer appears to be variable. Crystallization data on the periplasmic region of FepE and a FepE 76 
mutant conferring a shorter LPS Oag chain length show that both form nonamer structures 77 
(Kalynych et al., 2012; Tocilj et al., 2008). In contrast, cryo-electron microscopy studies on the 78 
full-length FepE reconstituted into proteoliposomes suggests a preference for a hexameric state 79 
(Larue et al., 2009).   80 
 81 
Several studies on FepE and other PCP1a proteins have been undertaken to define functional 82 
regions that affect LPS Oag modal chain length determination (Daniels & Morona, 1999; Franco et 83 
al., 1998; Kalynych et al., 2011; Kintz & Goldberg, 2011; Marolda et al., 2008; Papadopoulos & 84 
Morona, 2010; Purins et al., 2008; Tocilj et al., 2008). Franco et al. showed that site-directed 85 
mutations made in the periplasmic region of E. coli O2 Wzz at residues D90 and L91 altered LPS 86 
Oag modal chain length (Franco et al., 1998). While in S. flexneri WzzBSF, mutagenesis of residue 87 
K267 in the periplasmic domain and altering residues in the TM regions resulted in significant 88 
changes (Daniels & Morona, 1999). A later study on WzzBSF also identified mutations made in the 89 
coiled-coil regions of WzzBSF which conferred partial defects on LPS Oag modal chain length 90 
(region I), eliminated WzzBSF function (region II) or had no effect on LPS Oag modal chain length 91 
(region III) (Marolda et al., 2008). Purins et al. (2008) also showed that mutations made in selected 92 
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coil-coiled domains region of S. flexneri WzzpHS2 could result in loss of modality (Purins et al., 93 
2008). In E. coli FepE, mutations in the periplasmic region at residues D95V, E133, K201, Q232, 94 
R208 and D315 did not appear to effect LPS Oag modal chain length but a double mutation at 95 
residues D225V and E297A conferred a slightly shorter LPS Oag modal chain length (Tocilj et al., 96 
2008). Interestingly, a recent study by Kintz et al. using Pseudomonas aeruginosa Wzz2 showed 97 
that a mutation at residue 321 located within the second coil-coiled region of the protein resulted in 98 
shortened LPS Oag modal chain length depending on the amino acid (aa) introduced (Kintz & 99 
Goldberg, 2011). Since PCP proteins are predicted to share similar structural folds (Tocilj et al., 100 
2008), these studies suggest that specific aa rather than specific regions of PCP1a proteins affect 101 
regulation of LPS Oag modal chain length. More recently, a study using in-frame linker insertion 102 
mutagenesis on WzzBSF identified periplasmic sites which altered the LPS Oag modal chain length 103 
to varying degrees (Papadopoulos & Morona, 2010), classifying them into 5 mutant classes: I 104 
(function knockout), II & III (shorter that wild-type [WT] LPS Oag chains), IV (WT LPS Oag 105 
chains) and V (longer than WT LPS Oag chains). A study on chimeric molecules containing 106 
segments of WzzBSF and Salmonella typhimurium WzzBST has also identified regions spanning 107 
WzzBSF and FepE which conferred different LPS Oag modal chain lengths (Kalynych et al., 2011). 108 
To date, no additional site-directed mutagenesis has been undertaken to identify specific aa that 109 
affect FepE regulation of LPS Oag modal chain length.  110 
 111 
In this study, information previously obtained on residues important for WzzBSF function was used 112 
to predict residues in FepE which may affect function and hence to create a set of mutant constructs 113 
with single aa substitutions in FepE. LPS analysis on these constructs suggest that FepE residues 114 
located inside the oligomer cavity contribute to LPS Oag modal chain length determination and 115 
identified leucine 168 (L168) and aspartic acid 268 (D268) as residues important for VL Oag modal 116 
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chain length regulation. In addition to this, the role of TM region cysteine (Cys) residues was 117 
investigated, and a second set of mutants with single Cys substitutions was also constructed and 118 
characterised. The FepE mutants were used to investigate oligomer formation by cross-linking. The 119 
data suggest that FepE can form a number of oligomeric structures although no consistent 120 
correlation with an effect on function was found. Mass spectrometry (MS) of purified FepE 121 
oligomers cross-linked in situ suggests the in vivo size of the FepE oligomer is consistent with a 122 
maximum size of a hexamer.  123 
124 
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METHODS 125 
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this study are 126 
listed in Table 1. Strains were routinely grown at 37C in Luria-Bertani (LB) broth (10 g/liter 127 
Tryptone, 5 g/litre yeast extract, 5 g/litre NaCl) with aeration for 16 h, subcultured 1/20 into fresh 128 
broth and grown to an OD600 of ~0.8. Induction was carried out with 1 mM IPTG, followed by 129 
growth for another 3 h. Antibiotics were used at the following concentrations: 100 μg ampicillin ml-130 
1; 50 μg kanamycin ml-1; and 100 μg streptomycin ml-1. 131 
 132 
Mutagenesis. Site-directed mutagenesis was carried out following the QuikChange Lightning 133 
protocol (Stratagene) with complementary primers containing nucleotides encoding random aa 134 
(NNN) or specific nucleotide substitutions (Table S1). The latter were designed to alter charge or 135 
hydrophobicity of the residues at the mutated position. The expression plasmid pQE30-wzzFepE 136 
(encoding for His6-FepE) (Tocilj et al., 2008) was used as a template for the construction of mutant 137 
genes. Mutant constructs were confirmed by DNA sequencing with pQE primers ET11-13 (Table 138 
S1), prior to electroporation into S. flexneri RMA4053, a S. flexneri Y wzz::kan strain (lacking 139 
pHS2) and carrying pCDFDuet-1 (encoding lacIq) (Table 1). Electroporation and preparation of 140 
electrocompetent cells were prepared as previously described (Purins et al., 2008). 141 
 142 
SDS-PAGE and Western immunoblotting. Bacteria were grown and induced as described above, 143 
harvested by centrifugation, and resuspended in 1x sample buffer (Lugtenberg et al., 1975). Protein 144 
samples were heated at 100C for 5 mins, except for N-[4-(p-azidosalicylamido)butyl]-3’-(2’-145 
pyridyldithio)propionamide (APDP) treated samples which were heated at 60C for 5 min, prior to 146 
SDS-PAGE on 12% or 15% gels. Protein gels were either stained with Coomassie R-250, or 147 
subjected to Western immunoblotting on nitrocellulose membrane (Medos) with polyclonal FepE 148 
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antibodies (obtained from a rabbit following immunisation with purified FepE116-2193 protein 149 
provided by Prof. M. Cygler) at 1/500 dilution. Detection was performed with goat anti-rabbit 150 
horseradish-peroxidase-conjugated antibodies (KPL) and chemiluminescence reagent (Sigma). The 151 
molecular mass standards used for Coomassie Blue stained gels were Low Molecular Weight-SDS 152 
marker (Quantum Scientific) and Novex Sharp (Invitrogen) for MS analysis. BenchMark protein 153 
ladder (Invitrogen) was used for Western immunoblots.   154 
 155 
LPS PAGE and silver staining. LPS samples and gels were prepared as described previously 156 
(Murray et al., 2003; Papadopoulos & Morona, 2010). 157 
 158 
FepE protein purification. Cells were grown and induced as described above in 200 ml LB broth, 159 
harvested by centrifugation (9,800xg, 10 min, 4C, Beckman J2-21M Induction Drive Centrifuge) 160 
and resuspended in 15 ml NaPO4 buffer (50 mM NaPO4, 500 mM NaCl, pH 7), sonicated and re-161 
centrifuged to remove cell debris. Whole membrane (WM) pellets were collected by 162 
ultracentrifugation (126,000xg, 1 h, 4C, Beckman Coulter Optima L-100 XP Untracentrifuge) and 163 
solubilised in 1 ml NaPO4 buffer containing 1% (w/v) SDS for 2 h at RT prior to re-164 
ultracentrifugation (as above). Solubilised FepE in the supernatant fraction was mixed with 100 l 165 
Profinity IMAC resin (BIO-RAD #156-0133) for 1 h at RT, washed three times with NaPO4 166 
buffer containing 0.008% (w/v) SDS, four times with NaPO4 buffer containing 0.008% (w/v) SDS 167 
and 20 mM imidazole, and then eluted with 200 l NaPO4 buffer containing 1% (w/v) SDS and 500 168 
mM imidazole, pH 7. Eluted protein was mixed 1:1 with 2X sample buffer and ~5 l samples were 169 
analysed by SDS-PAGE. Gels were stained with Coomassie Blue to visualise protein bands.  170 
 171 
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Chemical cross-linking analysis. Cells grown and induced in 200 ml LB broth were harvested by 172 
centrifugation as above, resuspended in 15 ml NaPO4 buffer, disrupted by sonication and re-173 
centrifuged to remove cell debris. The sonicated cell extract containing WM vesicles was incubated 174 
with and without 500 M APDP (Thermo Scientific #27720) for 1 h at RT (in the dark), and then 175 
exposed to UV light for 15 min with a 365 nm UV lamp (Thermo Scientific #95035) at a distance 176 
of 10 cm on ice, followed by quenching with 0.3 M Tris-HCl (pH 7) for 5 min. APDP reacts with 177 
the SH groups of Cys residues by a disulfide exchange reaction which is cleavable with β-ME. 178 
Following UV irradiation, its photoreactive azide group reacts with neighbouring molecules and 179 
establishes a cross-link. One ml volumes of treated and untreated samples were collected and mixed 180 
1:1 with 2X sample buffer (with and without beta-mercaptoethanol [-ME]) for analysis by SDS-181 
PAGE. Gels were subjected to Western immunoblotting with FepE antibodies. Affinity purification 182 
of APDP treated and untreated proteins was carried with the remaining ~14 ml of samples by 183 
ultracentrifugation and solubilisation of WM pellets in NaPO4 buffer containing 1% (w/v) SDS, 184 
followed by protein elution from Profinity IMAC resin as described above. 185 
 186 
LC-eSI-IT mass spectrometry. Liquid chromatography-electrospray ionisation ion-trap (LC-eSI-187 
IT) mass spectrometry (MS) was carried out by the Adelaide Proteomics Centre. Briefly, protein 188 
samples were electrophoresed on 4-12%-SDS polyacrylamide gels (Invitrogen #NPO322BOX) and 189 
Coomassie-stained bands of interest were excised, washed in 50 mM ammonium carbonate 190 
(NH4HCO3), destained with 30% acetonitrile (ACN) in 50 mM NH4HCO3, reduced with 0.5 M 191 
dithiothretiol in 100 mM NH4HCO3, followed by alkylation with 2.75 M iodoacetamide in 100 192 
M NH4HCO3. Samples were then digested with 100 ng trypsin in 5 mM NH4HCO3/10% ACN and 193 
extracted with 1% formic acid in water, 1% formic acid in 50% ACN and 100% ACN. The volumes 194 
of the resulting peptide extracts were reduced by vacuum centrifugation and resuspended with 0.1% 195 
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formic acid in 2% ACN prior to LC-eSI-IT MS analysis. LC-eSI-IT MS/MS was performed using 196 
an online 1100 series HPLC system (Agilent Technologies) and a HCT Ultra 3D-Ion-Trap mass 197 
spectrometer (Bruker Daltonics). MS and MS/MS spectra were subjected to peak detection and de-198 
convolution using DataAnalysis (Version 3.4, Bruker Daltonics), annotated using BioTools 199 
(Version 3.1, Bruker Daltonics) and submitted to MASCOT (Version 2.2) for protein identification. 200 
201 
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RESULTS  202 
Identification of putative sites that may affect FepE function 203 
To investigate FepE residues which may play a key role in its function, regions known to be 204 
important for Oag modal chain length determination in the FepE homologue from Shigella flexneri, 205 
WzzBSF, were analysed and compared to FepE. Despite overall low sequence identity (Fig. 1), both 206 
proteins are structurally similar (Kalynych et al., 2011; Kalynych et al., 2012; Tocilj et al., 2008) 207 
and belong to the same family of PCP1a proteins. Analysis of several WzzBSF mutants showed that 208 
mutational alterations made between aa 102-107, 128-131 and 219-232 consistently had an effect 209 
on Oag modal chain length determination (Daniels & Morona, 1999; Papadopoulos & Morona, 210 
2010; Morona, unpublished data). Guided by sequence alignment of the two proteins, FepE regions 211 
spanning aa 110-115, 168-172 and 259-274 were predicted to affect Oag modal chain length 212 
determination (Fig. 1). Twenty mutant constructs containing different aa substitutions as a result of 213 
either random or specific nucleotide mutagenesis were hence made at positions F111, V114, L168, 214 
T170, D268 and G274 to give pRMET1 – 15, pRMET38 - 40 and pRMET42 - 43 (Table 1). The 215 
locations of these targeted residues are mapped on the 3D structure of FepE (Tocilj et al., 2008) 216 
(Fig. 2a - c). None of the aa substitutions were predicted to have an effect on local secondary 217 
structure as determined by the JPRED 3 secondary structure prediction server (Cole et al., 2008).  218 
 219 
LPS Oag modal chain lengths conferred by FepE mutants  220 
Plasmids pQE30-wzzFepE (encoding for wild-type His6-FepE), pRMET1 – 15, pRMET38 – 40, 221 
pRMET42 - 43 (encoding for mutant His6-FepE proteins), and pQE30 were transformed into 222 
RMA4053 (Table 1) to investigate the LPS Oag modal chain length distribution mediated by each 223 
mutant construct. Analysis of the resulting LPS by SDS-PAGE and silver staining showed FepE 224 
conferred a VL Oag modal chain length of >80 Oag RUs (Fig. 3a, lane 1). No Oag modal chain 225 
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length was conferred by the control strain with pQE30 as expected (Fig. 3a, lane 2). FepE mutants 226 
with different aa substitutions at phenylalanine 111 (F111) conferred either slightly shortened Oag 227 
modal chain length (<VL Oag RUs) for F111V and F111G (Fig. 3a, lanes 3 & 5) or loss of Oag 228 
modal chain length regulation for F111P (Fig. 3a, lane 4), suggesting that different aa have a 229 
different effect at this site. F111P also showed less polymerization of LPS Oag than that seen in the 230 
control strain with pQE30 only (Fig. 3a, lane 2), suggesting that the F111P substitution also 231 
interferes with polymerization. V114P, a mutant with an aa substitution at nearby valine 114, had 232 
no detectable change in LPS Oag modal chain length (Fig. 3a, lane 6). 233 
 234 
Interestingly, FepE mutants with different aa substitutions at leucine 168 (L168) conferred LPS 235 
with consistently shortened Oag modal chain lengths of 18 to <VL Oag RUs for L168D, L168Q, 236 
L168A and L168P (Fig. 3a, lanes 7, 8, 9 & 11), with an arginine substitution conferring the shortest 237 
Oag modal chain length of 14 – 28 Oag RUs for L168R (Fig. 3a, lane 10). These results suggest 238 
that a positive charge at this site has a dramatic effect. Structurally, L168 is located at the bottom of 239 
the 3D structure of FepE (Fig. 2d - f). Substitutions made at nearby threonine 170 (T170) showed 240 
less of an effect with slightly shortened Oag modal chain lengths (<VL Oag RUs) conferred by 241 
T170C and T170D (Fig. 3a, lanes 12 & 14), and no change in Oag modal chain length conferred by 242 
T170R (Fig. 3a, lane 13). 243 
 244 
Different aa substitutions of aspartic acid 268 (D268) showed varied shortening of the LPS Oag 245 
modal chain length (Fig. 3a, lanes 15 - 22). D268Y, D268L and D268V conferred the shortest Oag 246 
modal chain lengths of 3 – 14 or 7 – 15 Oag RUs (Fig. 3a, lanes 15, 18 & 19), while D268G, 247 
D268N and D268R conferred shortened Oag modal chain lengths of 10 – 22, 9 – 18 and 10 to <VL 248 
Oag RUs respectively (Fig. 3a, lanes 16, 18 & 19). Notably, substitution of D268 with neutral aa 249 
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residues tyrosine (Y), asparagine (N), leucine (L), valine (V) and glycine (G) appeared to confer 250 
shorter Oag modal chain lengths than substitution of D268 with positively charged arginine (R). 251 
When D268 was substituted with negatively charged glutamic acid (E), a WT Oag modal chain 252 
length of >80 Oag RUs was conferred (Fig. 3a, lane 17), suggesting that conservation of a negative 253 
charge at this position is essential. Structurally, D268 is located at the top of the 3D structure of 254 
FepE (Fig. 2g - i). In contrast to all other mutational alterations investigated, a tryptophan (W) aa 255 
substitution at nearby glycine 274 (G274) resulted in a broad lengthening of the Oag chain length 256 
with loss of modality (Fig. 3a, lane 22). 257 
 258 
Western immunoblotting performed on whole cell lysates from S. flexneri strains expressing WT 259 
and mutant FepE proteins detected a band consistent with the size of the WT His6-FepE protein 260 
(~43 kDa) for all mutants except F111P which showed no expression (Fig. 3b, lane 4) and G274W 261 
which had a band at 32 kDa only (Fig. 3b, lane 22). These results suggest a correlation between loss 262 
of LPS Oag modal chain length regulation and absence of FepE production (Fig. 3b & Table 2). 263 
The lower molecular mass ~32 kDa band detected in most samples with anti-FepE antibodies may 264 
be either a degradation product or an altered conformation of His6-FepE (Fig. 3b). 265 
 266 
Mutagenesis of Cys residues in the TM regions of FepE 267 
FepE has only two cysteine (Cys) residues located at aa position C52 (TM1) and C354 (TM2) (Fig. 268 
1). To investigate if these Cys residues were required for function, mutants with single or double aa 269 
substitutions at positions C52 and C354 were created. Analysis of the LPS profiles conferred by 270 
different aa substitutions of C52 (C52Q, C52W, C52P and C52S) and C354 (C354S, C354D, 271 
C354G and C354A) showed no effect on LPS Oag modal chain length (Fig. S1). Likewise, when 272 
both C52 and C354 were mutated (C52S/C354A), no effect on WT Oag modal chain length was 273 
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observed (Fig. S1), suggesting that the TM region cysteines are not critical for LPS Oag modal 274 
chain length regulation. Western immunoblotting performed on whole cell lysates detected a band 275 
consistent with the size of the WT His6-FepE protein for all mutants, with slightly less protein 276 
detected for C52Q and C52P (Table 2). 277 
 278 
Introduction of Cys residues in aa positions not affecting FepE function 279 
In a new approach to investigating the structure of FepE in membranes, Cys directed cross-linking 280 
was undertaken using APDP, a membrane permeable and heterobifunctional cross-linker with a 281 
spacer arm of ~21 Å. In addition to using the native FepE TM region Cys residues, to assist in 282 
cross-linking we also introduced Cys residues in the periplasmic domain of FepE at aa positions 283 
that did not affect its LPS Oag modal chain length regulation (Fig. 1). 284 
 285 
FepE residues D95, E133, K201, R208, Q232 and D315 which did not appear to affect function in 286 
Tocilj et al. (2008) were altered to Cys by site-directed mutagenesis on His6-FepE. The locations of 287 
these targeted residues are mapped on the 3D structure of FepE (Fig. 2j – k) with the exception of 288 
E133; E133 resides in a disordered region not seen in the crystal structure, so its approximate 289 
location is indicated in Fig. 2j – k. Analysis of the LPS conferred by these mutant His6-FepE-Cys 290 
proteins (Fig. 4a & Table 2) showed that E133C, Q232C and D315C conferred WT Oag modal 291 
chain lengths of >80 Oag RUs and hence were not affected in function (Fig. 4a, lanes 4, 6 & 7). 292 
D95C and K201C conferred slightly shortened LPS Oag modal chain lengths (<VL Oag RUs) (Fig. 293 
4a, lanes 3 & 8), while R208C conferred a shortened Oag modal chain length of 20 to <VL Oag 294 
RUs (Fig. 4a, lane 5). Western immunoblotting performed on whole cell lysates detected a band 295 
consistent with the size of the WT His6-FepE protein (~43 kDa) for all mutants (Fig. 4b, lanes 2 – 296 
8). FepE mutants E133C, Q232C and D315C were hence chosen for subsequent experiments. 297 
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 298 
In situ cross-linking of FepE, C52S/C354A and FepE-Cys mutants 299 
The ability of FepE and C52S/C354A to form higher order oligomers was then investigated by 300 
APDP cross-linking using cell lysates from strains expressing the proteins. Western 301 
immunoblotting analysis on FepE with 2 TM region Cys residues showed readily detectable ~43 302 
kDa (monomeric) and ~86 kDa (dimeric) forms of FepE in the untreated sample (Fig. 5a, lanes 1 & 303 
2). Treatment of FepE with UV only as a control showed similar results to the untreated control 304 
(Fig. 5a, lanes 3 & 4). When FepE was treated with APDP, the ~43 kDa (monomeric) and ~86 kDa 305 
(dimeric) forms were detected plus a new high molecular weight (HMW) band of >180 kDa, 306 
indicating the presence of higher order FepE oligomerisation (Fig. 5a, lane 5). In the presence of β-307 
ME, this HMW band was greatly reduced, suggesting that it arose due to cross-linking of FepE 308 
monomers by APDP (Fig. 5a, lane 6). Analysis of C52S/C354A with both TM region Cys residues 309 
mutated detected only the ~43 kDa (monomeric) and ~86 kDa (dimeric) forms in untreated and 310 
APDP treated samples (Fig. 5b, lanes 1-6), suggesting that the HMW band of >180 kDa detected in 311 
FepE sample is due to cross-linking at the TM Cys residues and that the TM regions are close 312 
together.  313 
 314 
The ability of E133C, Q232C, and D315C to form oligomers was then investigated. Unexpectedly, 315 
in both untreated and UV treated control samples of E133C, bands were detected at ~43 kDa 316 
(monomeric), ~86 kDa (dimeric), between 115 - 182 kDa (intermediate species) and at >180 kDa 317 
(HMW) (Fig. 5c, lanes 1- 4). These results suggest stable oligomer formation is exhibited by this 318 
mutant in the absence of cross-linker. APDP treatment of E133C (Fig. 5c, lane 5) resulted in a 319 
banding profile similar to that for likewise treated FepE (Fig. 5a, lane 5) but with the addition of the 320 
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intermediate band. Treatment with -ME resulted in detectable ~43 kDa (monomeric) and ~86 kDa 321 
(dimeric) species only (Fig. 5c, lanes 2, 3 & 6), as seen for FepE. 322 
 323 
To investigate whether the native FepE TM Cys residues contributed to the E133C banding profile, 324 
an E133C mutant with aa substitutions at both the TM region Cys residues was created 325 
(C52S/C354A/E133C). Analysis of C52S/C354A/E133C treated with and without APDP (Fig. 5f, 326 
lanes 1 - 6) showed the same banding profile detected for E133C (Fig. 5c, lanes 1 - 6), suggesting 327 
that the intermediate and HMW bands observed for E133C are a consequence of the Cys at position 328 
E133. Interestingly, the bands were also sensitive to -ME (Fig. 5f, lane 2, 4 & 6).  329 
 330 
When the Q232C mutant protein was investigated, bands were also detected at ~43 kDa 331 
(monomeric), ~86 kDa (dimeric), between 115 - 182 kDa (faint intermediate) and at >180 kDa 332 
(faint HMW) in the untreated sample (Fig. 5d, lanes 1 & 3), suggesting that this mutant also 333 
exhibits stable oligomer formation. Like E133C, the intermediate and HMW bands were sensitive 334 
to -ME (Fig. 5d, lanes 2, 4 & 6). Following APDP treatment, Q232C showed an increase in the 335 
HMW band (Fig. 5d, lane 5). In contrast, the D315C mutant protein showed a cross-linking profile 336 
similar to FepE, with the ~43 kDa (monomeric) and ~86 kDa (dimeric) bands detected in untreated 337 
and UV treated samples (Fig. 5e, lanes 1-4), and the additional HMW form detected in the APDP 338 
treated sample (Fig. 5e, lane 5). Treatment with -ME showed loss of the HMW form (Fig. 5e, lane 339 
6) as seen for FepE (Fig. 5a, lane 6).  340 
 341 
Hence, the higher oligomer forms of FepE were detectable either depending on the presence of an 342 
additional Cys residue (in the case of E133C and Q232C) or the addition of APDP (in the case of 343 
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FepE and D315C). The apparent sizes of most bands detected were consistent with multiples of the 344 
FepE monomer.  345 
 346 
In situ cross-linking of FepE mutants 347 
Having established a baseline for the cross-linking of FepE by APDP, we next investigated whether 348 
mutations that affected LPS Oag modal chain length regulation had an effect on FepE oligomer 349 
formation. Several FepE mutants that conferred a shortened LPS Oag modal chain length (L168R, 350 
L168P, D268Y and D268G) were hence subjected to APDP cross-linking analysis (Fig. 5 & Table 351 
2). Untreated samples containing L168R, L168P and D268Y had the ~43 kDa (monomeric) form 352 
but showed loss of the ~86 kDa (dimeric) form (Fig. 5g - i, lanes 1 – 2). In the UV only and APDP 353 
treated samples, the ~84 kDa form was detected for all 3 mutants (Fig. 5g - i, lanes 3 - 6), 354 
suggesting that the L168R, L168P and D268Y mutations may either prevent or destabilise dimer 355 
formation under the conditions used, but this can be restored by UV and/or APDP treatment. The 356 
HMW band was detected in all APDP treated samples (Fig. 5g - i, lanes 5) as seen for FepE (Fig. 357 
5a, lane 5). In contrast, the ~86 kDa (dimeric) form was detected in both untreated and APDP 358 
treated samples of D268G (Fig. 5j, lanes 1 - 6), indicating that shortened LPS Oag modal chain 359 
length due to the D268G mutation (Fig. 3a, lane 16) is not solely due to the absence of the ~86 kDa 360 
form. APDP treated sample of D268G (Fig. 5j, lane 5) also showed a similar banding profile to 361 
FepE (Fig. 5a, lane 5). Cross-linking analysis undertaken on all other FepE mutants (Fig. S2 & 362 
Table 2) show that while specific substitutions in FepE can affect the observed banding profile 363 
(F111P, F111G, T170C, D268V & G274W), no consistent correlation between banding profile and 364 
the effect of the mutation on LPS Oag modal chain length could be made (Table 2). It is interesting 365 
to note that the intermediate band previously observed for E133C and Q232C (Fig. 5c & d) is also 366 
present for T170C having a Cys substitution (Fig. S2h). 367 
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 368 
Mass spectrometry analysis on purified FepE and E133C 369 
Our cross-linking data suggested that in situ FepE can form oligomers but whether these oligomers 370 
are solely composed of FepE or FepE associated with other proteins is unknown. To investigate the 371 
identity of the proteins present in the higher oligomer structures of FepE as detected above, strains 372 
expressing either His6-FepE or His6-FepEE133C were incubated with and without APDP, and 373 
proteins were affinity purified via their His6 tags. E133C was selected based on its ability to 374 
oligomerise the presence and absence of APDP and still confer a WT Oag chain length distribution. 375 
The profile of the affinity purified FepE proteins were first verified by Coomassie Blue staining on 376 
standard SDS 12% gels (Fig. 6a), and then separated on SDS 4 - 12% gels for MS analysis (Fig. 377 
6b). Unexpectedly, on the SDS 4 - 12% gels the ~86 kDa (dimeric) form migrated as a doublet and 378 
the HMW band separated into several bands between 140 – 260 kDa (Fig. 6b). Interestingly, all 379 
oligomers formed by His6-FepE and His6-FepEE133C did not exceed an apparent molecular mass of 380 
260 kDa (Fig. 6b).  381 
 382 
MS identification was carried out on the ~43 kDa (monomeric) and ~86 kDa doublet bands (from 383 
both untreated and APDP treated samples), and on several of the separated HMW bands between 384 
140 – 260 kDa (from APDP treated sample) for FepE (Fig. 6b, lanes 2 & 4). For E133C, the ~43 385 
kDa (monomeric) band and the intermediate species (which now appeared to migrate at ~100 kDa) 386 
were analysed (from untreated and APDP treated samples), as well as several of the separated 387 
HMW bands between 140 – 260 kDa (from APDP treated sample) (Fig. 6b, lanes 6 & 8). MS 388 
analysis of all the above mentioned protein bands cut from the SDS-PAGE gels showed the 389 
presence of FepE as the major protein in all of the oligomeric FepE protein bands (Table S2 & Fig. 390 
S3), suggesting that in vivo, FepE likely exists as a homogeneous oligomer of up to 6 protomers.  391 
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DISCUSSION 392 
In this study we constructed and characterised a set of His6-FepE mutant proteins to identify the 393 
regions that affect FepE function in conferring VL Oag modal chain length and to investigate FepE 394 
higher oligomer formation by cross-linking with APDP. Previous mutagenesis studies suggested 395 
that for WzzBSF, different regions of the protein contribute to LPS Oag modal chain length 396 
regulation (Daniels & Morona, 1999; Franco et al., 1998; Papadopoulos & Morona, 2010). Using 397 
this data (as well as unpublished data) and guided by secondary structure-based sequence 398 
alignments of WzzBSF and FepE, regions spanning aa 110 - 115, 168 - 172 and 259 - 274 in FepE 399 
were predicted to affect LPS Oag modal chain length conferred by FepE. It is interesting to note 400 
that these regions corresponded to intermediate regions between  helices and  sheets (Fig. 1) 401 
where a higher degree of structural flexibility is expected. His6-FepE mutants with various 402 
substitutions at F111, V114, L168, T170, D268 and G274W within the three regions were found to 403 
have an impact on LPS Oag modal chain length (Fig. 3 & Table 2), suggesting that these residues 404 
are critical for FepE function. Based on sequence alignment (Tocilj et al., 2008), residues F111, 405 
D268 and G274 are conserved across the FepE, WzzB and WzzBpHS2 PCP1a proteins of E. coli, S. 406 
typhimurium and S. flexneri, while a neutral charge residue at positions 114, 168 and 170 appears to 407 
be conserved across the same PCP1a proteins (Tocilj et al., 2008). 408 
 409 
Several substitutions made at position L168, located between 2 and 3 sheets of FepE, conferred 410 
consistently shortened LPS Oag modal chain lengths of 18 to <VL Oag RUs (L168D, L168Q, 411 
L168A and L168P), with one mutant conferring 14 – 28 Oag RUs (L168R) (Fig. 3 & Table 2). 412 
Hence, L168 appears to be essential for conferring VL Oag modal chain length and the presence of 413 
a leucine residue at this site appears to be critical. Linker insertion (5aa) mutations made in the 414 
same region in WzzBSF, which confers a short LPS Oag modal chain length of 10 – 17 Oag RUs, 415 
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were shown to increase the LPS Oag modal chain length to 16 – 25 Oag RUs (Papadopoulos & 416 
Morona, 2010), suggesting that the same regions are important for Oag chain length control for 417 
both PCP1a proteins. 418 
 419 
Substitutions at D268, located between the 6 and 7 helices of FepE, conferred the most dramatic 420 
shortening of LPS Oag modal chain lengths in this study. Out of 7 mutants, 2 mutants conferred an 421 
LPS Oag modal chain length of 3 – 14 Oag RUs (D268Y and D268L), and 4 mutants (D268V, 422 
D268G, D268N and D268R) conferred varied LPS Oag modal chain length of 7 – 15, 10 – 22, 9 – 423 
18 and 10 to <VL Oag RUs, respectively (Fig. 3 & Table 2). The remaining mutant FepED268E, 424 
harbouring a conserved negatively charged residue substitution, conferred WT Oag modal chain 425 
length (Fig. 3 & Table 2), suggesting that maintenance of the negative charge at this position is 426 
critical. This correlates with data by Kalynch et al. (2011), whereby substitution or deletion of the 427 
FepE aa region 256 – 273 (where D268 is located), resulted in shortened LPS Oag chain lengths. 428 
We report for the first time 2 specific residues, L168 and D268, which are essential for FepE 429 
function in LPS Oag modal chain length determination. Similar to data for WzzBSF, our findings 430 
support that more than one region of the protein is important for determining LPS Oag chain length 431 
modal specificity (Daniels & Morona, 1999; Franco et al., 1998; Papadopoulos & Morona, 2010). 432 
 433 
Our data also support the previous suggestion that the internal cavity of the FepE crystal structure 434 
oligomer may play a role in Oag polysaccharide length control (Tocilj et al., 2008), as the majority 435 
of His6-FepE mutants shown to affect function had mutational alterations at positions located inside 436 
the FepE oligomer (F111, V114, L168, T170, D268 and G274W) (Fig. 2 & Table 2). Notably, two 437 
of these positions, D268 and G274, are located in the FepE region spanning aa residues 240-299 438 
which correlates to the WzzBSF segment spanning 200-255 based on sequence alignment (Tocilj et 439 
 22 
 
al., 2008). Kalynych et al. (2011) showed that this functionally important WzzBSF segment was 440 
predominately located on the external surface of the WzzBSF oligomer and hypothesised that the 441 
external surface of chain length regulators might represent the principal site of modal length 442 
control. Residues D268 and G274 located within this same region of FepE however, point towards 443 
the internal cavity of the oligomer and still affect LPS Oag modal chain length (Fig. 2 & Fig. 3). 444 
Similarly, residue L168 shown to consistently shorten the LPS Oag modal chain length as a result 445 
of different aa substitutions, points towards the internal cavity of the FepE oligomer (Fig. 2). Based 446 
on this, we propose that the nascent Oag linked Und-PP chains are threaded into the FepE oligomer 447 
barrel during Wzy dependant polymerisation. Once filling has occurred, a conformation change in 448 
the FepE oligomer releases the Oag linked Und-PP chains, and hence determines Oag modal length 449 
(Fig. S4). Substitution with different aa inside the FepE oligomer may result in less filling of the 450 
barrel and/or an earlier change in FepE oligomer conformation to release shorter model chain 451 
lengths. In regards to other PCP1a proteins, their different barrel sizes and/or requirements for 452 
different degrees of interaction with Oag chains may trigger the change in conformation that 453 
releases the Oag linked Und-PP chains for ligation to the lipid A core by WaaL (Fig. S4).   454 
 455 
In previous studies on WzzBSF it was found that introduction of mutations at the beginning of either 456 
TM1 or within TM2 (Daniels & Morona, 1999; Papadopoulos & Morona, 2010) can affect function 457 
and protein cross-linking profile. Mutational alterations made in the TM regions of FepE in this 458 
study, specifically altering the only two Cys residues (C52 and C354) found in FepE, had no affect 459 
on function (Table 2 & Fig. S1). However, other aa residues located in the TM region have not yet 460 
been investigated. Analysis of a double TM Cys mutant C52S/C354A treated with APDP only 461 
detected the ~43 kDa (monomeric) and ~86 kDa (dimeric) forms of the protein (Fig. 5b), whereas 462 
an additional HMW band was detectable in the APDP treated sample of FepE (with TM cysteines) 463 
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(Fig. 5a). Since APDP is a membrane permeable probe these results suggest that at least some of the 464 
HMW bands in FepE, are due to cross-linking at the TM Cys residues, and that the FepE TMs are 465 
in close proximity to each other in the cytoplasmic membrane.  466 
 467 
Substitution at position E133 had no effect on FepE function in this study (Fig. 3) and in a previous 468 
study (Tocilj et al., 2008). Structurally, E133 is located at the bottom of the crystal structure of the 469 
FepE oligomer in an undefined region between 4 and 5 helices, which appears to protrude out 470 
from the oligomer, close to the inner membrane. Unexpectedly, E133C showed a stable oligomeric 471 
form between 115 - 182 kDa (intermediate form) (Fig. 5c) despite the absence of chemical cross-472 
linker, which might have arisen by oxidation either in situ or during sample preparation. Analysis of 473 
APDP treated E133C showed both the intermediate form and the HMW band were detected and 474 
that they were -ME sensitive (Fig. 5c). These bands were also present in the C52S/C354A/E133C 475 
mutant lacking the TM cysteines (Fig. 5f). This data suggests that E133C promotes stable FepE 476 
interactions, possibly through other interactions promoted and stabilised as a result of the disulfide 477 
bond formation at position E133. This is not unique to E133C as Q232C and T170C also had a 478 
similar effect (Table 2).  479 
 480 
Previous data for WzzBSF also suggested that the dimer form may be important in determining Oag 481 
modal chain length (Papadopoulos & Morona, 2010). However, we were unable to find a 482 
correlation between the dimer form of FepE and LPS Oag modal chain length regulation in this 483 
study. L168R, L168P, D268Y and D268G all conferred shortened LPS Oag modal chain lengths 484 
(Fig. 3) but only 3 mutants (L168R, L168P and D268Y) showed loss of the ~86 kDa (dimeric) form 485 
in untreated cross-linking samples (Fig. 5g – j). Upon treatment with APDP, the dimeric form was 486 
detected for all mutants (Fig. 5g – f), and the APDP cross-linking profile was no different to FepE 487 
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(Fig. 5a). Differences obtained between the two studies may be due to differences in the methods 488 
used and the protein studied; the mutational alterations used are different, and subtle changes used 489 
in this study may affect function but not have a detectable effect on oligomer formation.  490 
 491 
No consistent relationship was observed between higher order oligomer formation and the observed 492 
LPS profile of the mutants studied (Table 2, Fig. 4, 5 & S2) and hence these results suggest that the 493 
oligomeric form of FepE may not necessarily correlate to function. Kalynych et al. (2012) observed 494 
that a FepE mutant although conferring a shortened LPS Oag modal chain length had the same 3D 495 
structure as FepE (Kalynych et al., 2012; Tocilj et al., 2008), suggesting that Oag modal chain 496 
length regulation by FepE is likely controlled by aa residues along the structure of the oligomer, 497 
rather than either the oligomer size, or conformational changes.  498 
 499 
X-ray crystallographic studies of the periplasmic domain of FepE show that the protein forms a 500 
nonamer (Tocilj et al., 2008), while cryo-electron microscopy analysis on the full-length FepE 501 
protein showed that FepE most likely exists as a hexamer state (Larue et al., 2009). Cross-linking 502 
analysis with formaldehyde suggests that detergent-solubilised FepE can form dimeric and 503 
tetrameric complexes that can assemble into higher molecular weight oligomer forms (Larue et al., 504 
2009). In this study, in situ treatment of FepE and FepE mutants with APDP cross-linker showed 505 
that FepE was able to form a number of higher order oligomers (Fig. 5 & S2) that did not appear to 506 
be larger than 260 kDa (Fig. 6), suggesting that FepE may exist as a hexamer in vivo. Analysis of 507 
FepE proteins affinity purified from strains expressing FepE and E133C by MS showed that all 508 
Coomassie Blue stained bands investigated consisted of FepE derived peptides (Table S2), 509 
confirming that FepE can form homogeneous oligomeric structures of varying sizes in vivo.  510 
 511 
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In summary, our results show that residues located inside the FepE oligomer within intermediate 512 
regions between  helices and  sheets, in particular L168 and D268, are important for FepE 513 
regulation of VL Oag modal chain length. FepE oligomer formation as detected by APDP cross-514 
linking does not appear to correlate with an effect of mutations on function, and our MS data 515 
suggest that the in vivo size of FepE is consistent with a maximum size of a hexamer. 516 
 517 
Acknowledgements 518 
This study was supported by a program grant from the National Health and Medical Research 519 
Council of Australia to R. Morona. 520 
521 
 26 
 
REFERENCES 522 
al-Hendy, A., Toivanen, P. & Skurnik, M. (1992). Lipopolysaccharide O side chain of Yersinia 523 
enterocolitica O:3 is an essential virulence factor in an orally infected murine model. Infect Immun 60, 524 
870-875. 525 
 526 
Cole, C., Barber, J. D. & Barton, G. J. (2008). The Jpred 3 secondary structure prediction server. 527 
Nucleic Acids Res 36, W197-201. 528 
 529 
Crawford, R. W., Keestra, A. M., Winter, S. E., Xavier, M. N., Tsolis, R. M., Tolstikov, V. & 530 
Baumler, A. J. (2012). Very long O-antigen chains enhance fitness during Salmonella-induced colitis 531 
by increasing bile resistance. PLoS Pathog 8, e1002918. 532 
 533 
Daniels, C. & Morona, R. (1999). Analysis of Shigella flexneri wzz (Rol) function by mutagenesis and 534 
cross-linking: wzz is able to oligomerize. Mol Microbiol 34, 181-194. 535 
 536 
Franco, A. V., Liu, D. & Reeves, P. R. (1998). The wzz (cld) protein in Escherichia coli: amino acid 537 
sequence variation determines O-antigen chain length specificity. J Bacteriol 180, 2670-2675. 538 
 539 
Hong, M. & Payne, S. M. (1997). Effect of mutations in Shigella flexneri chromosomal and plasmid-540 
encoded lipopolysaccharide genes on invasion and serum resistance. Mol Microbiol 24, 779-791. 541 
 542 
Kalynych, S., Ruan, X., Valvano, M. A. & Cygler, M. (2011). Structure-guided investigation of 543 
lipopolysaccharide O-antigen chain length regulators reveals regions critical for modal length control. J 544 
Bacteriol 193, 3710-3721. 545 
 546 
Kalynych, S., Yao, D., Magee, J. & Cygler, M. (2012). Structural characterization of closely related 547 
O-antigen lipopolysaccharide (LPS) chain length regulators. J Biol Chem 287, 15696-15705. 548 
 549 
Kintz, E., Scarff, J. M., DiGiandomenico, A. & Goldberg, J. B. (2008). Lipopolysaccharide O-550 
antigen chain length regulation in Pseudomonas aeruginosa serogroup O11 strain PA103. J Bacteriol 551 
190, 2709-2716. 552 
 553 
Kintz, E. N. & Goldberg, J. B. (2011). Site-directed mutagenesis reveals key residue for O antigen 554 
chain length regulation and protein stability in Pseudomonas aeruginosa Wzz2. J Biol Chem 286, 555 
44277-44284. 556 
 557 
 27 
 
Larue, K., Kimber, M. S., Ford, R. & Whitfield, C. (2009). Biochemical and structural analysis of 558 
bacterial O-antigen chain length regulator proteins reveals a conserved quaternary structure. J Biol 559 
Chem 284, 7395-7403. 560 
 561 
Lugtenberg, B., Meijers, J., Peters, R., van der Hoek, P. & van Alphen, L. (1975). Electrophoretic 562 
resolution of the "major outer membrane protein" of Escherichia coli K12 into four bands. FEBS Lett 563 
58, 254-258. 564 
 565 
Marolda, C. L., Haggerty, E. R., Lung, M. & Valvano, M. A. (2008). Functional analysis of 566 
predicted coiled-coil regions in the Escherichia coli K-12 O-antigen polysaccharide chain length 567 
determinant Wzz. J Bacteriol 190, 2128-2137. 568 
 569 
Morona, R., Van Den Bosch, L. & Daniels, C. (2000). Evaluation of Wzz/MPA1/MPA2 proteins 570 
based on the presence of coiled-coil regions. Microbiology 146, 1-4. 571 
 572 
Morona, R., Purins, L., Tocilj, A., Matte, A. & Cygler, M. (2009). Sequence-structure relationships 573 
in polysaccharide co-polymerase (PCP) proteins. Trends Biochem Sci 34, 78-84. 574 
 575 
Murray, G. L., Attridge, S. R. & Morona, R. (2003). Regulation of Salmonella typhimurium 576 
lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second 577 
Wzz. Mol Microbiol 47, 1395-1406. 578 
 579 
Murray, G. L., Attridge, S. R. & Morona, R. (2005). Inducible serum resistance in Salmonella 580 
typhimurium is dependent on wzz(fepE)-regulated very long O antigen chains. Microbes Infect 7, 1296-581 
1304. 582 
 583 
Najdenski, H., Golkocheva, E., Vesselinova, A., Bengoechea, J. A. & Skurnik, M. (2003). Proper 584 
expression of the O-antigen of lipopolysaccharide is essential for the virulence of Yersinia 585 
enterocolitica O:8 in experimental oral infection of rabbits. FEMS Immunol Med Microbiol 38, 97-106. 586 
 587 
Papadopoulos, M. & Morona, R. (2010). Mutagenesis and chemical cross-linking suggest that Wzz 588 
dimer stability and oligomerization affect lipopolysaccharide O-antigen modal chain length control. J 589 
Bacteriol 192, 3385-3393. 590 
 591 
Purins, L., Van Den Bosch, L., Richardson, V. & Morona, R. (2008). Coiled-coil regions play a role 592 
in the function of the Shigella flexneri O-antigen chain length regulator WzzpHS2. Microbiology 154, 593 
1104-1116. 594 
 595 
Raetz, C. R. & Whitfield, C. (2002). Lipopolysaccharide endotoxins. Annu Rev Biochem 71, 635-700. 596 
 28 
 
 597 
Samuel, G. & Reeves, P. (2003). Biosynthesis of O-antigens: genes and pathways involved in 598 
nucleotide sugar precursor synthesis and O-antigen assembly. Carbohydr Res 338, 2503-2519. 599 
 600 
Tocilj, A., Munger, C., Proteau, A. & other authors (2008). Bacterial polysaccharide co-601 
polymerases share a common framework for control of polymer length. Nat Struct Mol Biol 15, 130-602 
138. 603 
 604 
Van Den Bosch, L., Manning, P. A. & Morona, R. (1997). Regulation of O-antigen chain length is 605 
required for Shigella flexneri virulence. Mol Microbiol 23, 765-775. 606 
 607 
Van Den Bosch, L. & Morona, R. (2003). The actin-based motility defect of a Shigella flexneri rmlD 608 
rough LPS mutant is not due to loss of IcsA polarity. Microb Pathog 35, 11-18. 609 
 610 
Zhang, L., Radziejewska-Lebrecht, J., Krajewska-Pietrasik, D., Toivanen, P. & Skurnik, M. 611 
(1997). Molecular and chemical characterization of the lipopolysaccharide O-antigen and its role in the 612 
virulence of Yersinia enterocolitica serotype O:8. Mol Microbiol 23, 63-76. 613 
 614 
 615 
 616 
617 
 29 
 
 Table 1 618 
 619 
TABLE 1. Bacterial strains and plasmids 
Strain/plasmid Description Source/Reference 
XL10 Gold endA1 glnV44 recA1 thi-1 gyrA96 relA1 lac Hte Δ(mcrA)183 
Δ(mcrCB-hsdSMR-mrr)173 tetR F'[proAB lacIqZΔM15 
Tn10(TetR Amy CmR)] 
Stratagene 
RMA4053 S. flexneri PE860 serotype Y wzz::kanr, cured of virulence 
plasmid and pHS-2, carrying pCDFDuet-1 
Laboratory stock 
Plasmids   
pCDFDuet-1 expression vector carrying lacI q, SmR Novagen 
pQE30 IPTG inducible, expression vector, AmpR Qiagen 
pQE30-wzzFepE pQE30 with E. coli O157:H7 fepE gene, AmpR Tocilj et al. (2008) 
pRMET1 pQE30::fepE (F111 --> P) encoding F111P This study 
pRMET2 pQE30::fepE (F111 --> G) encoding F111G This study 
pRMET3 pQE30::fepE (V114 --> P) encoding V114P This study 
pRMET4 pQE30::fepE (L168 --> D) encoding L168D This study 
pRMET5 pQE30::fepE (L168 --> Q) encoding L168Q This study 
pRMET6 pQE30::fepE (T170 --> D) encoding T170D This study 
pRMET7 pQE30::fepE (D268 --> R) encoding D268R This study 
pRMET8 pQE30::fepE (D268 --> L) encoding D268L This study 
pRMET9 pQE30::fepE (F111 --> V) encoding F111V This study 
pRMET10 pQE30::fepE (L168 --> A) encoding L168A This study 
pRMET11 pQE30::fepE (L168 --> R) encoding L168R This study 
pRMET12 pQE30::fepE (T170 --> C) encoding T170C This study 
pRMET13 pQE30::fepE (T170 --> R) encoding T170R This study 
pRMET14 pQE30::fepE (D268 --> V) encoding D268V This study 
pRMET15 pQE30::fepE (G274 --> W) encoding G274W This study 
pRMET16 pQE30::fepE (D95 --> C) encoding D95C This study 
pRMET17 pQE30::fepE (E133 --> C) encoding E133C This study 
pRMET18 pQE30::fepE (R208 --> C) encoding R208C This study 
pRMET19 pQE30::fepE (Q232 --> C) encoding Q232C This study 
pRMET20 pQE30::fepE (D315 --> C) encoding D315C This study 
pRMET21 pQE30::fepE (K201 --> C) encoding K201C This study 
pRMET22 pQE30::fepE (C52 --> Q) encoding C52Q This study 
pRMET23 pQE30::fepE (C52 --> W) encoding C52W This study 
pRMET24 pQE30::fepE (C52 --> P) encoding C52P This study 
pRMET25 pQE30::fepE (C52 --> S) encoding C52S This study 
pRMET26 pQE30::fepE (C354 --> S) encoding C354S This study 
pRMET27 pQE30::fepE (C354 --> D) encoding C354D This study 
pRMET28 pQE30::fepE (C354 --> G) encoding C354G This study 
pRMET29 pQE30::fepE (C354 --> A) encoding C354A This study 
pRMET30 pQE30::fepE (C52 --> S, C354 --> A) encoding C52S/C354A This study 
pRMET38 pQE30::fepE (D268 --> Y) encoding D268Y This study 
pRMET39 pQE30::fepE (D268 --> G) encoding D268G This study 
 30 
 
pRMET40 pQE30::fepE (L168 --> P) encoding L168P This study  
pRMET41 pQE30::fepE (C52 --> S, C354 --> A, E133 --> C) encoding 
C52S/C354A/E133C 
This study 
pRMET42 pQE30::fepE (D268 --> E) encoding D268E This study  
pRMET43 pQE30::fepE (D268 --> N) encoding D268N This study  
620 
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Table 2 621 
 622 
TABLE 2. Summary of His6-FepE mutants LPS phenotypes and protein detection 
His6-FepE 
mutant 
Location on 3D  
crystal structure* 
LPS modal 
length† 
Protein 
detection‡ Apparent oligomer size (kDa)
§ 
Before After 
FepE VL +++ 43, 86 43, 86, >180 
pQE30 Non-modal - nd nd 
F111V  between 2 & 3 (in)  <VL +++ 43 43, 86, >180 
F111P between 2 & 3 (in) Non-modal - 43 43 
F111G between 2 & 3 (in) <VL + 43 43 
V114P beginning of 3 (in) VL +++ 43 43, 86, >180 
L168D between 2 & 3 (in) 18 - <VL +++ 43, 86 43, 86, >180 
L168Q between 2 & 3 (in) 18 - <VL +++ 43 43, 86, >180 
L168A between 2 & 3 (in) 18 - <VL +++ 43, 86 43, 86, >180 
L168R between 2 & 3 (in) 14 - 28 +++ 43 43, 86, >180 
L168P between 2 & 3 (in) 18 - <VL +++ 43 43, 86, >180 
T170C between 2 & 3 (in) <VL +++ 43, 86, 115-182 43, 86, 115-182, >180 
T170R  between 2 & 3 (in) VL +++ 43 43, 86, >180 
T170D between 2 & 3 (in) <VL +++ 43, 86 43, 86, >180 
D268Y between 6 & 7 (in) 3 - 14 +++ 43 43, 86, >180 
D268G between 6 & 7 (in) 10 - 22 +++ 30, 43, 86 43, 86, >180 
D268E between 6 & 7 (in) VL +++ 43 43, 86, >180 
D268N between 6 & 7 (in) 9 - 18 +++ 43 43, 86, >180 
D268R between 6 & 7 (in) 10 - <VL +++ 30, 43 30, 43, 86, >180 
D268L between 6 & 7 (in) 7 - 15 +++ 43 43, 86, >180 
D268V  between 6 & 7 (in) 7 - 15 +++ 43 43 
G274W  beginning of 7 (in) Non-modal - 30, 43 43 
  
His6-FepE-TM mutants   
C52Q undefined (TM1) VL ++ nd nd 
C52W undefined (TM1) VL +++ nd nd 
C52P undefined (TM1) VL ++ nd nd 
C52S undefined (TM1) VL +++ nd nd 
C354S undefined (TM2) VL +++ nd nd 
C354D undefined (TM2) VL +++ nd nd 
C354G undefined (TM2) VL +++ nd nd 
C354A undefined (TM2) VL +++ nd nd 
C52S/C354A refer above VL +++ 43, 86 43, 86 
C52S/C354A/E133C VL +++ 43, 86, 115-182, >180 43, 86, 115-182, >180 
  
His6-FepE-Cys mutants   
D95C between 1 & 2 (in) <VL +++ nd nd 
E133C undefined (out) VL +++ 43, 86, 115-182, >180 43, 86, 115-182, >180 
K201C 6 helix (out) <VL +++ nd nd 
R208C 6 helix (out) 20 - <VL +++ nd nd 
Q232C 6 helix (in) VL +++ 43, 86, 115-182, >180 43, 86, 115-182, >180 
D315C between 8 & 4 (out) VL +++ 43, 86 43, 86, >180 
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* Based on FepE crystal structure PDB 3b8n & Fig. 1; in, inside; out, outside; TM1/TM2, predicted TM regions 1 or 2 
 † Average length of Oag RUs; VL, very long LPS (>80 Oag RUs); <VL, less than very long LPS; >VL, more than very 
long LPS 
‡ +++, wild type; +, less than wild type; -, not detected. 
§ Bands detected before and after cross-linking with 500M APDP; 115-182, intermediate band in text; >180, HMW 
band in text; nd, not done 
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Figure 2 629 
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Figure 3 633 
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Figure 4 637 
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Figure 5  641 
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Figure 6 645 
 646 
 647 
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FIGURE LEGENDS 649 
Fig. 1. Regions in FepE targeted for mutation. (a) The aa sequence alignment of FepE (NP_286314) 650 
and WzzBSF (X71970) adapted from Tocilj et al. (2008) showing conserved residues (black shading), 651 
residues with strongly similar properties (yellow shading), TM regions (grey boxed) and the location of 652 
selected  helices and  strands near putative areas predicted to affect FepE function in determining 653 
Oag modal chain length (circled in green). The aa positions predicted to affect function (F111, V114, 654 
L168, T170, D268 and G274) are indicated by red arrows, the positions targeted for directed Cys 655 
substitutions (D95, E133, K201, R208, Q232, D315) by purple arrows, and the TM region Cys are 656 
indicated by blue arrows; (b) Topology diagram of FepE monomer (PDB 3b8n) showing the same 657 
putative areas of interest (circled in green) (adapted from Tocilj et al. (2008)).   658 
 659 
Fig. 2. Location of residues targeted for mutation on the 3D structures of FepE. The location of 660 
the targeted residues for mutation are mapped on the 3D structures of FepE (PDB 3b8n). Residues 661 
F111 (red), V114 (blue), L168 (green), T170 (yellow), D268 (cyan) and G274 (magenta) mapped on 662 
(a) FepE monomer and (b & c) FepE nonamer (side view & mid-section view, respectively). L168 663 
(green) mapped on (d) FepE monomer (with its aa substitutions highlighted in white), and (e & f) FepE 664 
nonamer (side view & bottom view, respectively). D268 (cyan) mapped on (g) FepE monomer (and its 665 
aa substitutions highlighted in white), and (h & i) FepE nonamer (side view & bottom view, 666 
respectively). Residues targeted for Cys substitution inside the FepE oligomer (D95 and Q232 in 667 
orange) and outside the FepE oligomer (E133, K201, R208 and D315 in pink) are mapped on (j) FepE 668 
monomer, and (k) FepE nonamer (side view).   669 
 670 
Fig. 3. Analysis of LPS profile conferred by FepE mutants. (a) LPS was isolated and detected from 671 
whole cell lysates of S. flexneri strains expressing FepE, pQE30 and His6-FepE mutant proteins 672 
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(indicated above). The first 15 Oag RUs are indicated on the side of the gel. Mutants containing aa 673 
substitutions in similar putative regions are grouped. Each lane contains ~2 x 108 bacterial cells of each 674 
strain; (b) Western blots on whole cell lysates expressing the above proteins were probed with rabbit 675 
anti-FepE antiserum. The size of the full length His6-FepE protein (~43 kDa) and the degraded/altered 676 
His6-FepE (~32 kDa) are indicated. Each lane contains 5 x 107 bacterial cells of each strain. 677 
 678 
Fig. 4. Analysis of LPS profile conferred by His6-FepE-Cys mutants. (a & c) LPS was isolated and 679 
detected from whole cell lysates of S. flexneri strains expressing FepE, pQE30 and mutant His6-FepE-680 
Cys proteins (indicated above). The first 15 Oag RUs are indicated on the side of the gel. Each lane 681 
contains ~2 x 108 bacterial cells of each strain; (b & d) Western blots on whole cell lysates expressing 682 
the above proteins were probed with rabbit anti-FepE antiserum. The size of the full length His6-FepE 683 
protein (~43 kDa) and the degraded/altered His6-FepE protein (~32 kDa) are indicated. Each lane 684 
contains 5 x 107 bacterial cells of each strain.  685 
 686 
Fig. 5. Chemical cross-linking of His6-FepE-Cys mutants. S. flexneri strains expressing FepE and 687 
His6-FepE-Cys mutant proteins as indicated were prepared and incubated with 500 M APDP and 688 
exposure to UV (APDP); no APDP and exposure to UV only (UV); and no APDP and UV exposure 689 
(Untreat). Samples were mixed in sample buffer with (+) and without (-) -ME. Western blots were 690 
probed with rabbit anti-FepE antiserum. The HMW band (black star) and intermediate species between 691 
115 - 182 kDa () are indicated in APDP treated samples (lane 5). The position of the ~86 kDa 692 
(dimeric) form is indicated by black arrows on the side of the gels (lane 1). The ~30 kDa band in 693 
untreated sample of D268G is indicated by a black square. Each lane contains ~5 x 107 bacterial cells.  694 
 695 
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Fig. 6. Analysis of purified FepE and E133C proteins by MS. Protein were affinity purified from 696 
untreated and APDP treated samples of S. flexneri strains expressing His6-FepE and His6-FepEE133C. 697 
All samples were mixed in sample buffer with (+) and without (-) β-ME, heated at 60C for 5 mins, and 698 
electrophoresed on SDS 12% polyacrylamide gels (a) and a SDS 4-12% polyacrylamide gel (b), 699 
followed by Coomassie staining. The ~43 kDa (monomeric) form (■), ~86 kDa (dimeric) form (▲), 700 
intermediate species between 115 - 182 kDa (), and separated HMW bands between 140 – 260 kDa 701 
(black star) are indicated in APDP treated samples (lanes 4 & 8). Protein bands excised for MS analysis 702 
are numbered as indicated and summarized in Table S2. 703 
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SUPPLEMENTARY FIGURE LEGENDS 
 
Fig. S1. Analysis of LPS profile conferred by His6-FepE TM mutants. Whole cell lysates of S. 
flexneri strains expressing FepE, pQE30 and mutant His6-FepE TM proteins as indicated were 
proteinase-K treated and electrophoresed on a SDS 15% polyacrylamide gel, followed by 
detection of LPS by silver-staining (Murray et al., 2003). The first 15 Oag RUs are indicated on 
the side of the gel. Each lane contains ~2 x 108 bacterial cells of each strain. 
 
Fig. S2. Chemical cross-linking of His6-FepE mutants. S. flexneri strains expressing FepE and 
His6-FepE mutant proteins as indicated were harvested, resuspended in NaPO4 buffer and 
disrupted by sonication, then incubated with 500 M APDP and exposure to UV (APDP); no 
APDP and exposure to UV only (UV); and no APDP and UV exposure (Untreat). Samples were 
mixed in sample buffer with (+) and without (-) -ME, heated at 60C for 5 mins, and 
electrophoresed on a SDS 12% polyacrylamide gel followed by Western immunoblotting with 
anti-FepE antibodies. The HMW band (black star) and the intermediate species between 115 - 
182 kDa () are indicated in APDP treated samples (lane 5). The position of the ~86 kDa 
(dimeric) form is indicated by black arrows on the side of the gels (lane 1). The ~30 kDa band in 
untreated samples of D268R and G274W is indicated by a black square. Each lane contains ~5 x 
107 bacterial cells.  
 
Fig. S3. FepE and E133C protein sequence showing identified peptides. The aa sequences of 
FepE and E133C correspond to MASCOT entries FEPE_ENHT and FEPE_ENHTC (modified to 
contain modified Cys at position E133), respectively. The peptides identified from MS for the 
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monomeric species in untreated samples of FepE and E133C, Bands 1 and 10 respectively, are 
mapped on the aa sequence as indicated in red. 
 
Fig. S4. Proposed model of Oag chain length regulation by FepE. 
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Supplementary Table S1 
Table S1. Oligonucleotides used in this study  
Primer 
name Oligonucleotide sequence (5' - 3')* Target† 
AA (and nt) 
change‡ 
 
ETR1 CCTGTTTATCAAGAAGNNNCAGTCGGTTAGCTTGCTGG F111 V(GTA), 
P(CCC), 
G(GGT) 
ETR2 Reverse complement of ETR1  
ETR3 CAAGAAGTTTCAGTCGCCGAGCTTGCTGGAAGAG V114 P(CCG) 
ETR4 Reverse complement of ETR3  
ETR5 AAGATGAACCGTCANNNTATACCTCCTGGACGC L168 D(GAC), 
Q(CAG), 
A(GCG), 
R(CGG), 
P(CCA) 
ETR6 Reverse complement of ETR5  
ETR7 GATGAACCGTCACTGTATNNNTCCTGGACGCTAAG T170 C(TGT), 
R(CGT), 
D(GAC) 
ETR8 Reverse complement of ETR7  
ETR9 CGTTAAAGATGACCCCNNNTTCTCTATTTCTCTCGGC D268 Y(TAC), 
G(GGA), 
E(GAA), 
N(AAT), 
R(CGT), 
L(CTC), 
V(GTG) 
ETR10 Reverse complement of ETR9  
ETR11 GATTTCTCTATTTCTCTCTGGGCAGACGGTATTGAACGC G274 W(TGG) 
ETR12 Reverse complement of ETR11  
ETR13 CTTCGTGTGCTGGATCTGTGTATCAAAATTGATCGTACA D95 C(TGT) 
ETR14 Reverse complement of ETR13  
ETR15 GTGATGGACCAATTAAAATGTGCGAAAATCGACGAACTG E133 C(TGT) 
ETR16 Reverse complement of ETR15  
ETR17 CTCTGCGTTGGTGGTGTGTGAGTCGATAGAAAACG K201 C(TGT) 
ETR18 Reverse complement of ETR17  
ETR19 AGAGTCGATAGAAAACGTCTGTAATAAACTGGAGATCAAA R208 C(TGT) 
ETR20 Reverse complement of ETR19  
ETR21 CCGCATTAAAATGAAAAATTGTCTTGATGCAAACATTCAGCGC Q232 C(TGT) 
ETR22 Reverse complement of ETR21  
ETR23 CAGTTAACAAAAGCAAATATCAACTGTGTGAATTTTACGCCG D315 C(TGT) 
ETR24 Reverse complement of ET23  
ETR25 CGTTTTTGCGTTTGCCNNNGCAGGCTTGCTGATCT C52 Q(CAA), 
W(TGG), 
P(CCG), 
S(TCT) 
ETR26 Reverse complement of ET25  
ETR27 CGTTTTTGCGTTTGCCTCTGCAGGCTTGCTGATCT C52 S(TCT) 
ETR28 Reverse complement of ET27  
ETR29 CGGGATGGTGGCTNNNGGTAGCGTGTTATTGCG  C354 S(AGC), 
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ETR30 Reverse complement of ET29  D(GAT), 
G(GGG), 
A(GCT) 
ETR31 CGGGATGGTGGCTGCTGGTAGCGTGTTATTGCG C354 A(GCT) 
ETR32 Reverse complement of ETR31  
    
ET11 CCCGAAAAGTGCCACCTG pQE30  
ET12 GGTCATTACTGGAGTCTTG pQE30  
ET13 CGGATAACAATTTCACACAG pQE30  
       
* Underlined sequences indicate the nucleotides that undergo site directed mutagenesis 
† Residues targeted for mutation in FepE 
‡ Amino acid (AA) and nucleotide (nt) changes made at targeted residues 
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Supplementary Table S2 
 
TABLE S2. Mass Spectrometry analysis of FepE & E133C 
Band 
number* Sample Description* Gene† 
No. of peptides 
identified 
% FepE sequence 
coverage‡ 
FepE 
   Band 1 Untreated Monomeric species  FepE 217  45% 
   Band 2 Untreated Dimeric species FepE 20 31% 
   Band 3 Untreated Dimeric species FepE 26 31% 
   Band 4 APDP Monomeric species FepE 56 44% 
   Band 5 APDP Dimeric species - lower band FepE 108 41% 
   Band 6 APDP Dimeric species - upper band FepE 102 48% 
   Band 7 APDP HMW species  FepE 32 28% 
   Band 8 APDP HMW species  FepE 41 31% 
   Band 9 APDP HMW species  FepE 23 28% 
E133C 
   Band 10 Untreated Monomeric species  E133C 244 48% 
   Band 11 Untreated Intermediate species E133C 305 51% 
   Band 12 APDP Monomeric species  E133C 285 45% 
   Band 13 APDP Intermediate species E133C 56 45% 
   Band 14 APDP HMW species E133C 59 60% 
   Band 15 APDP HMW species E133C 57 60% 
   Band 16 APDP HMW species E133C  54 50% 
   Band 17 APDP HMW species E133C 46 51% 
   Band 18 APDP HMW species E133C 48 50% 
            
* Bands excised for MS analysis are numbered as shown in Fig. 6 
† aa sequences FepE and E133C corresponds to MASCOT entries FEPE_ENHT and FEPE_ENHTC (modified 
to contain modified Cys at position E133), respectively 
‡ % sequence coverage of identified peptides on FepE or E133C aa sequence 
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Supplementary Figure S1 
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Supplementary Figure S2 
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Supplementary Figure S3 
 
Band 1  
Match to: FEPE_ENHT Score: 1192 
Elizabeth Tran Translation of Escherichia coli O157:H7 FepE 
  
Nominal mass (Mr): 42222; Calculated pI value: 6.08 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 45% 
  
Matched peptides shown in Red 
  
     1 MSSLNIKQGS DAHFPDYPLA SPSNNEIDLL NLISVLWRAK KTVMAVVFAF  
    51 ACAGLLISFI LPQKWTSAAV VTPPEPVQWQ ELEKTFTKLR VLDLDIKIDR  
   101 TEAFNLFIKK FQSVSLLEEY LRSSPYVMDQ LKEAKIDELD LHRAIVALSE  
   151 KMKAVDDNAS KKKDEPSLYT SWTLSFTAPT SEEAQTVLSG YIDYISALVV  
   201 KESIENVRNK LEIKTQFEKE KLAQDRIKMK NQLDANIQRL NYSLDIANAA  
   251 GIKKPVYSNG QAVKDDPDFS ISLGADGIER KLEIEKAVTD VAELNGELRN  
   301 RQYLVEQLTK ANINDVNFTP FKYQLSPSLP VKKDGPGKAI IVILSALIGG  
   351 MVACGSVLLR YAMASRKQDA MMADHLV 
  
Band 10 
Match to: FEPE_ENHTC Score: 5169 
Cys-Modified Elizabeth Tran translation E133C 
  
Nominal mass (Mr): 42285; Calculated pI value: 6.39 
Fixed modifications: Carbamidomethyl (C) 
Variable modifications: Oxidation (M) 
Cleavage by Trypsin: cuts C-term side of KR unless next residue is P 
Sequence Coverage: 48% 
  
Matched peptides shown in Red 
  
     1 MSSLNIKQGS DAHFPDYPLA SPSNNEIDLL NLISVLWRAK KTVMAVVFAF  
    51 ACAGLLISFI LPQKWTSAAV VTPPEPVQWQ ELEKTFTKLR VLDLDIKIDR  
   101 TEAFNLFIKK FQSVSLLEEY LRSSPYVMDQ LKCAKIDELD LHRAIVALSE  
   151 KMKAVDDNAS KKKDEPSLYT SWTLSFTAPT SEEAQTVLSG YIDYISALVV  
   201 KESIENVRNK LEIKTQFEKE KLAQDRIKMK NCLDANIQRL NYSLDIANAA  
   251 GIKKPVYSNG QAVKDDPDFS ISLGADGIER KLEIEKAVTD VAELNGELRN  
   301 RQYLVEQLTK ANINDVNFTP FKYQLSPSLP VKKDGPGKAI IVILSALIGG  
   351 MVACGSVLLR YAMASRKQDA MMADHLV 
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Supplementary Figure S4 
 
 
 
 
 
 
